Common Stroke Medication, Edaravone, can Cure Alzheimer’s Disease, Says Study

Study reveals that Edaravone prevents the accumulation of toxins that steadily degenerates cells that eventually leads to loss of cognitive functions.

A team of researchers from Australia and China found that a drug prescribed to treat stroke victims could alleviate the progressive mental deterioration of Alzheimer’s disease.

Edaravone, a commonly prescribed drug in Asia for those who have suffered a stroke, shows significant reversal of mental decline typically associated with Alzheimer’s disease. Scientists hope the drug may help in improving memory as well as learning abilities.

Therapies That Reduce Apolipoprotein E may Have the Potential to Treat Alzheimer�s Disease
Researchers suggest that therapies that can reduce the levels of apolipoprotein E (apoE) could have the potential to treat neurodegenerative disorders such as Alzheimer disease.

Edaravone prevents the accumulation of toxins that steadily degenerates cells that eventually leads to loss of cognitive functions.

Researchers tested the drug on mice; the team showed that the drug effectively blocks the toxin function of the amyloid beta cells. The drug effectively fights the primary causes of Alzheimer’s disease.

Researchers said that further research is needed to know whether the drug could help people with Alzheimer’s disease. Edaravone cannot be prescribed unless the drug passes human trials in which patients are being specifically treated for Alzheimer’s disease.

Antibodies That can Help Effectively Treat Alzheimer�s Disease Identified
A new study reports on the development of antibody treatments that can prevent the accumulation of a toxic protein, known as tau proteins, in the brain.

Postponing Retirement Might Help Ward Off Alzheimer�s Disease
A large scale study reveals that people who tend to postpone their retirement by a few years were less likely to develop Alzheimer’s disease.

Source-Medindia

Cognitive Effects of Alzheimer�s Disease Compounded When Combined With Cerebrovascular Disease
Two different studies have confirmed anecdotal information on patients with both Alzheimer's disease (AD) and cerebrovascular disease (CVD).